The U.S. Food and Drug Administration approved the Keytruda combination in malignant pleural mesothelioma in September. Keytruda, a cancer drug that harnesses a patient's immune system to fight tumors ...

Packages start at $79.99 a month, and you get seven days to try the service for free. Sling TV is one of our favorite cord-cutter services — and one of the best ways to watch F1 online.

Commissions do not affect our editors' opinions or evaluations. Medical billing software helps doctors and medical offices automate the healthcare billing process. Finding the right computer ...

"We're launching important new products to solve for unmet medical needs, which have significant commercial potential," Merck Chairman and CEO Robert Davis said on the call. "We're advancing novel ...

The pace of mergers and acquisitions remained strong this week, with Kraft Heinz, Engineering software firm Altair, and Spirit Airlines grabbing headlines. Here's a list of other key deals this week: ...

Merck, a leading pharmaceutical company, has embarked on a digital transformation by signing a Memorandum of Understanding with technological innovator Siemens. This partnership will propel digital ...

Table of Contents Members of certain organizations, such as AARP, may be eligible for a discount on a medical alert system. Individuals with Medicaid or private health insurance could be eligible ...

Merck’s acquisition of Modifi Biosciences will give it access to preclinical cancer drug candidates that target DNA repair processes. Modifi Biosciences, a spin out of Yale University founded in 2021, ...

Merck a global leader in science and technology has announced a new partnership with four Cork secondary schools. Merck will provide students from schools in Carrigtwohill, Midleton and Cobh with ...

Originally serving military servicemembers and veterans, PenFed Credit Union has since opened its membership to anyone who opens an online savings account and deposits at least $5. Why We Like It ...

Merck has acquired Modifi Biosciences, a Connecticut-based biotech, for up to $1.3bn. The acquisition strengthens Merck’s oncology portfolio as the company looks to offset revenue losses from the ...